Concepedia

Ruth F. Keir

RF

Statistics

Publications

4

Citations

127

H-Index

4

Active since

1985

Affiliations

Pfizer (United Kingdom)(Current)

Ruth F. Keir is an author at Pfizer (United Kingdom) specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

1985–2008

4

Publications

4

Comparison of potency of α<sub>2</sub>‐adrenoceptor antagonists<i>in vitro</i>: evidence for heterogeneity of α<sub>2</sub>‐adrenoceptors

V A Alabaster, Ruth F. Keir, Christopher J. Peters · British Journal of Pharmacology · 1986 · 51 citations · Full text

Comparison of activity of alpha-adrenoceptor agonists and antagonists in dog and rabbit saphenous vein

V A Alabaster, Ruth F. Keir, Christopher J. Peters · Naunyn-Schmiedeberg s Archives of Pharmacology · 1985 · 36 citations

, , +9

Inhaled adenosine A2A receptor agonists for the treatment of chronic obstructive pulmonary disease

Simon J. Mantell, Peter T. Stephenson, Sandra M. Monaghan et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 23 citations · Full text

, , +6

Pharmacological profile of UK-74,505, a novel and selective PAF antagonist with potent and prolonged oral activity.

M. J. PARRY, V A Alabaster, H E Cheeseman et al. · PubMed · 1994 · 17 citations

1–4 of 4